Evidence map

ReviewObesity pillars2025

Appropriate use of the fixed-dose, extended-release combination of naltrexone and bupropion as treatment for obesity in primary care.

Ethan LazarusPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40160495